Journal
Advances in Radiation Oncology
Publication Date
8-1-2024
Volume
9
Issue
8
First Page
101532
Document Type
Open Access Publication
DOI
10.1016/j.adro.2024.101532
Rights and Permissions
Lowentritt BH, Jani AB, Helfand BT, Uchio EM, Morris MA, Michalski JM, Chau A, Davis P, Chapin BF, Schuster DM; SPOTLIGHT Study Group. Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study. Adv Radiat Oncol. 2024 May 1;9(8):101532. doi: 10.1016/j.adro.2024.101532. © 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Lowentritt, Benjamin H; Jani, Ashesh B; Helfand, Brian T; Uchio, Edward M; Morris, Michael A; Michalski, Jeff M; Chau, Albert; Davis, Phillip; Chapin, Brian F; Schuster, David M; and SPOTLIGHT Study Group, "Impact of clinical factors on 18F-flotufolastat detection rates in men with recurrent prostate cancer: Exploratory analysis of the phase 3 SPOTLIGHT study." Advances in Radiation Oncology. 9, 8. 101532 (2024).
https://digitalcommons.wustl.edu/oa_4/4992
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
